32295-50-4

1,3-Dioxan-5-ol, 2-phenyl-, 4-methylbenzenesulfonate, cis-

1-Oxa-3-azaspiro[4.5]decane, 2-cyclohexyl-3-[(4-nitrobenzoyl)oxy]-

1H-Purine-2,6-dione,7-[(2-chloro-4-fluorophenyl)methyl]-3,7-dihydro-8-[4-(4-methoxyphenyl)-1-piperazinyl]-1,3-dimethyl-

1H-Pyrrole-3-carboxylic acid,2-methyl-5-phenyl-1-[2-(trifluoromethyl)phenyl]-, methyl ester

1H-Purine-2,6-dione,7-[(2-chloro-6-fluorophenyl)methyl]-8-[[2-(dimethylamino)ethyl]amino]-3,7-dihydro-1,3-dimethyl-

1H-Purine-2,6-dione,7-[3-[(5,5-dimethyl-3-oxo-1-cyclohexen-1-yl)amino]propyl]-3,7-dihydro-1,3-dimethyl-

1H-Purine-2,6-dione,7-[(2-chloro-6-fluorophenyl)methyl]-8-[[2-(diethylamino)ethyl]ethylamino]-3,7-dihydro-1,3-dimethyl-

1H-Purine-2,6-dione,7-[(2-chloro-6-fluorophenyl)methyl]-3,7-dihydro-8-(4-hydroxy-1-piperidinyl)-1,3-dimethyl-

1H-Purine-2,6-dione,7-[(2-bromo-5-fluorophenyl)methyl]-3,7-dihydro-1,3-dimethyl-8-(4-phenyl-1-piperazinyl)-

7l4-[1,2,4]Thiadiazolo[5,1-e][1,2,3]thiadiazole,1,6-dihydro-6-methyl-1,3,5-triphenyl-

1,3,2-Dioxastannole,4,5-diphenyl-2,2-bis[2,4,6-tris(1-methylethyl)phenyl]-

1-Oxaspiro[2.4]heptane,4-(3,6-dimethyl-7-oxabicyclo[4.1.0]hept-3-yl)-4-methyl-

2,4,6-Cycloheptatrien-1-one, 4-bromo-2-[(difluoroboryl)oxy]-

2-Pentanone, 4-[(4S)-3,4-dihydro-4,7-dimethyl-1-naphthalenyl]-, (4S)-

2H-Pyran-2,4(3H)-dione, 3-[(dimethylamino)methylene]-6-methyl-, (3Z)-

1-Oxaspiro[2.6]nonane, 4-(3-pentynyl)-

1-Oxa-5-azaspiro[2.4]hept-5-yloxy, 4,4,6,6-tetramethyl-7-methylene-

1H-Purine-2,6-dione,7-[(2-chloro-6-fluorophenyl)methyl]-8-(cyclopentylamino)-3,7-dihydro-1,3-dimethyl-

1H-Purine-2,6-dione,7-[(2-chloro-6-fluorophenyl)methyl]-3,7-dihydro-1,3-dimethyl-8-(4-methyl-1-piperazinyl)-

1H-Purine-2,6-dione,7-[[4-(1,1-dimethylethyl)phenyl]methyl]-3,7-dihydro-1,3-dimethyl-8-[4-(2-pyridinyl)-1-piperazinyl]-

1-Oxa-4,9-dithiacycloundeca-5,7-diene,5,6-dichloro-7-nitro-8-(octylthio)-

1H-Pyrrole-3-carboxylic acid,4,5-dihydro-5-oxo-4-[(2E)-1-oxo-3-phenyl-2-propenyl]-2-phenyl-, ethylester

1H-Purine-2,6-dione,7-[(2,6-dichlorophenyl)methyl]-8-[4-(2,4-dimethoxyphenyl)-1-piperazinyl]-3,7-dihydro-1,3-dimethyl-

1H-Purine-2,6-dione,7-[(2-bromo-5-fluorophenyl)methyl]-3,7-dihydro-1,3-dimethyl-8-[4-(phenylmethyl)-1-piperazinyl]-

1-Oxaspiro[4.11]hexadec-3-en-2-one

1H-Purine-2,6-dione,7-[(4-fluorophenyl)methyl]-3,7-dihydro-1,3-dimethyl-8-[4-[2-(4-morpholinyl)ethyl]-1-piperazinyl]-

triethyl[(2-methylpropyl)sulfanyl]stannane

5-methyl-6-(1H-pyrrol-2-ylmethyl)-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one

Butanoic acid, 2-[(dimethylamino)methylene]-3-oxo-, ethyl ester, (2Z)-

Benzothiazole, 2-[(3-phenyl-2-propenyl)thio]-

1H-Purine-2,6-dione,8-(3-amino-1-piperidinyl)-3,7-dihydro-3-methyl-7-(3-methyl-2-butenyl)-1-(1-methyl-2-oxo-2-phenylethyl)-

1H-Pyrrole-3-carboxylic acid,1-[(aminocarbonyl)amino]-4-(2-furanylcarbonyl)-4,5-dihydro-5-hydroxy-2-methyl-5-(trifluoromethyl)-, methyl ester

1H-Purine-2,6-dione,7-[(4-chlorophenyl)methyl]-8-[4-(2,4-dimethoxyphenyl)-1-piperazinyl]-3,7-dihydro-1,3-dimethyl-

4-(p-tolylsulfonyloxy)naphthalene-2-carboxylic acid

1H-Purine-2,6-dione,7-[(2,5-difluorophenyl)methyl]-3,7-dihydro-1,3-dimethyl-8-[(4-phenylbutyl)amino]-

1-Oxa-3-azaspiro[4.5]decan-6-ol, 2-phenyl-, (2R,5S,6R)-rel-

1H-Purine-2,6-dione,7-[[3,5-bis(trifluoromethyl)phenyl]methyl]-3,7-dihydro-1,3-dimethyl-8-[4-(2-pyridinyl)-1-piperazinyl]-

32295-50-4 msds

CAS No 32295-50-4 supplier

CASNo 32295-50-4 distributor

CAS # 32295-50-4 manufacturer

CAS Number 32295-50-4 safety

CAS RN 32295-50-4 wholesale

2026-10-11 Find 1,3-Dioxan-5-ol, 2-phenyl-, 4-methylbenzenesulfonate, cis-,CAS No.32295-50-4,Formula:C17H18O5S in ChemToTech